Prostate cancer management: pushing the diagnostic frontier - ESR Connect

RC 707 - Prostate cancer management: pushing the diagnostic frontier

  • 3 Lectures
  • 60 Minutes
  • 3 Speakers

No access granted. Register to watch.

Lectures

1
RC 707_1 - A. The role of MRI

RC 707_1 - A. The role of MRI

18:45Valeria Panebianco, Rome / IT

Learning Objectives
1. To illustrate the evolution of MRI in terms of technical and standardisational improvement.
2. To understand the clinical impact of MRI in the era of the prostate imaging reporting and data system
(PI-RADS).
3. To become familiar with the MRI strategies for risk-adapted prostate cancer diagnosis.

2
RC 707_2 - B. The role of molecular imaging: PSMA-PET/CT and PET/MR

RC 707_2 - B. The role of molecular imaging: PSMA-PET/CT and PET/MR

18:39Pascal A.T. Baltzer, Vienna / AT

Learning Objectives
1. To become familiar with the key clinical issues and imaging strategies for risk-adapted prostate cancer diagnosis.
2. To understand the significance and complementary roles of whole-body MRI and PSMA-PET/CT for tumour detection, (re)staging, as well as therapy planning and monitoring.
3. To learn the clinical indications for risk-adapted whole-body PSMA-PET/CT and PET/MRI according to current guidelines.

3
RC 707_3 - C. Theranostic approaches to prostate cancer management

RC 707_3 - C. Theranostic approaches to prostate cancer management

20:13Harun Ilhan, Munich / DE

Learning Objectives
1. To review and evaluate current approaches for hybrid imaging in prostate cancer.
2. To analyse the impact of imaging on several therapeutic approaches for prostate cancer.
3. To look ahead for future approaches for prostate cancer theranostics.

Description

RC 707-1
A. The role of MRI
Valeria Panebianco, Rome / IT
Learning Objectives
1. To illustrate the evolution of MRI in terms of technical and standardisational improvement.
2. To understand the clinical impact of MRI in the era of the prostate imaging reporting and data system
(PI-RADS).
3. To become familiar with the MRI strategies for risk-adapted prostate cancer diagnosis.
RC 707-2
B. The role of molecular imaging: PSMA-PET/CT and PET/MR
Pascal A.T. Baltzer, Vienna / AT
Learning Objectives
1. To become familiar with the key clinical issues and imaging strategies for risk-adapted prostate cancer diagnosis.
2. To understand the significance and complementary roles of whole-body MRI and PSMA-PET/CT for tumour detection, (re)staging, as well as therapy planning and monitoring.
3. To learn the clinical indications for risk-adapted whole-body PSMA-PET/CT and PET/MRI according to current guidelines.
RC 707-3
C. Theranostic approaches to prostate cancer management
Harun Ilhan, Munich / DE
Learning Objectives
1. To review and evaluate current approaches for hybrid imaging in prostate cancer.
2. To analyse the impact of imaging on several therapeutic approaches for prostate cancer.
3. To look ahead for future approaches for prostate cancer theranostics.

Abdominal and Gastrointestinal / Genitourinary

  • ESR MEMBERS €49
  • NON MEMBERS €99

Categories and Tags